Adam Schechter, Labcorp CEO
July 28, 2022 07:06 AM EDTUpdated 11:05 AM
Deals
Manufacturing

Lab­corp is spin­ning out its clin­i­cal de­vel­op­ment unit in ma­jor shake­up

Max Gelman

Senior Editor

Tyler Patchen

News Reporter

Lab­corp an­nounced this morn­ing that it is spin­ning out most of its CRO busi­ness, eight years af­ter its $6 bil­lion Co­v­ance ac­qui­si­tion.

Lab­corp will keep …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times